{"id":"https://openalex.org/W4361886300","doi":"https://doi.org/10.1158/1078-0432.22465850","title":"Supplementary Figures 1 & 2 from A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy","display_name":"Supplementary Figures 1 & 2 from A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361886300","doi":"https://doi.org/10.1158/1078-0432.22465850"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22465850","doi":"https://doi.org/10.1158/1078-0432.22465850","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465850","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22465850","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078745076","display_name":"Rashid Khalid Sayyid","orcid":"https://orcid.org/0000-0002-2133-569X","observed_orcids":["https://orcid.org/0000-0002-2133-569X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rashid K. Sayyid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073406780","display_name":"Karen M. Hersey","orcid":"https://orcid.org/0000-0002-0134-8813","observed_orcids":["https://orcid.org/0000-0002-0134-8813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Hersey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088476487","display_name":"Ranjena Maloni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ranjena Maloni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091361235","display_name":"Antonio Hurtado\u2010Coll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Hurtado-Coll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018908850","display_name":"Girish S. Kulkarni","orcid":"https://orcid.org/0000-0002-6929-6124","observed_orcids":["https://orcid.org/0000-0002-6929-6124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Girish Kulkarni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088388062","display_name":"Antonio Finelli","orcid":"https://orcid.org/0000-0003-4032-6120","observed_orcids":["https://orcid.org/0000-0003-4032-6120"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Finelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012397578","display_name":"Alexandre R. Zlotta","orcid":"https://orcid.org/0000-0003-2315-5809","observed_orcids":["https://orcid.org/0000-0003-2315-5809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre R. Zlotta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113642295","display_name":"Robert Hamilton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Hamilton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062125605","display_name":"Martin Edwin Gleave","orcid":"https://orcid.org/0000-0003-4235-0167","observed_orcids":["https://orcid.org/0000-0003-4235-0167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Gleave","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007710281","display_name":"Neil Eric Fleshner","orcid":"https://orcid.org/0000-0001-7407-7463","observed_orcids":["https://orcid.org/0000-0001-7407-7463"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil E. Fleshner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/degarelix","display_name":"degarelix","score":0.9950000047683716},{"id":"https://openalex.org/keywords/gnrh-agonist","display_name":"GnRH agonist","score":0.7919999957084656},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.878000020980835},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9700000286102295},{"id":"https://openalex.org/keywords/radical-prostatectomy","display_name":"radical prostatectomy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/bicalutamide","display_name":"bicalutamide","score":0.9539999961853027},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.9850000143051147},{"id":"https://openalex.org/keywords/alpha-methylacyl-coa-racemase","display_name":"AMACR","score":0.9309999942779541},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7200000286102295},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2780962315","wikidata":"https://www.wikidata.org/wiki/Q1988832","display_name":"Bicalutamide","level":5,"score":0.9793142080307007},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6961116194725037},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6450773477554321},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.542402446269989},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4704762101173401},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.41273656487464905},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3579409122467041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3056880235671997},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2795138359069824},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.2359497845172882},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1157751977443695}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22465850","doi":"https://doi.org/10.1158/1078-0432.22465850","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465850","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22465850.v1","doi":"https://doi.org/10.1158/1078-0432.22465850.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22465850.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22465850","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_1_2_from_A_Phase_II_Randomized_Open-Label_Study_of_Neoadjuvant_Degarelix_versus_LHRH_Agonist_in_Prostate_Cancer_Patients_Prior_to_Radical_Prostatectomy/22465850","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22465850","doi":"https://doi.org/10.1158/1078-0432.22465850","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465850","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361946165","https://openalex.org/W2533101571","https://openalex.org/W4361927111","https://openalex.org/W2600999145","https://openalex.org/W2318488640","https://openalex.org/W2324895803","https://openalex.org/W2341883213","https://openalex.org/W2316682120","https://openalex.org/W2793251629","https://openalex.org/W1898026383"],"abstract_inverted_index":{"Supplementary":[0,19],"Figure":[1,20],"1.":[2],"Immunohistochemical":[3,22],"expression":[4,23],"of":[5,24],"Ki-67":[6],"after":[7,28],"degarelix,":[8,29],"degarelix":[9,30],"and":[10,15,31,36],"bicalutamide,":[11,32],"or":[12,33],"LHRH":[13,34],"agonist":[14,35],"bicalutamide.":[16,37],"(ONLINE":[17,38],"ONLY)":[18,39],"2.":[21],"alpha-methylacyl-CoA":[25],"racemase":[26],"(AMACR)":[27]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}